IL6R and rheumatoid arthritis: In this regard, the use of two clinically approved IL-6R antagonists, tocilizumab (TCZ) and sarilumab (SAR), which are currently used for the treatment of rheumatoid arthritis, could be expected to play a crucial part in the treatment for severely ill patients.